These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 16338623

  • 1. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD, Stussi G, Passweg JR, Loberiza FR, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein GJ, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, Klumpp TR, Horowitz MM, Ringdén O, Barrett AJ, GVHD Working Committee of Center for International Blood and Marrow Transplant Research.
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [Abstract] [Full Text] [Related]

  • 2. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.
    Biol Blood Marrow Transplant; 2001 Dec; 7(11):620-30. PubMed ID: 11760150
    [Abstract] [Full Text] [Related]

  • 3. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?
    Mehta J, Powles R, Sirohi B, Treleaven J, Kulkarni S, Saso R, Tait D, Singhal S.
    Bone Marrow Transplant; 2002 May; 29(10):853-9. PubMed ID: 12058235
    [Abstract] [Full Text] [Related]

  • 4. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S, Miyamura K, Mori S, Akiyama H, Hirokawa M, Ohto H, Ashida H, Motoyoshi K, Japan Marrow Donor Program.
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [Abstract] [Full Text] [Related]

  • 5. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
    Blin N, Traineau R, Houssin S, Peffault de Latour R, Petropoulou A, Robin M, Larghero J, Ribaud P, Socié G.
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
    [Abstract] [Full Text] [Related]

  • 6. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G, Muntwyler J, Passweg JR, Seebach L, Schanz U, Gmür J, Gratwohl A, Seebach JD.
    Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M.
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [Abstract] [Full Text] [Related]

  • 12. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ.
    Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
    [Abstract] [Full Text] [Related]

  • 13. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings.
    Mehta J, Powles R, Horton C, Milan S, Singhal S, Treleaven J.
    Bone Marrow Transplant; 1995 Jun; 15(6):853-8. PubMed ID: 7581080
    [Abstract] [Full Text] [Related]

  • 14. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R, Van Riet I, Ben Othman T, Trullemans F, De Waele M, Van Camp B.
    Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
    Worel N, Greinix HT, Supper V, Leitner G, Mitterbauer M, Rabitsch W, Fischer G, Rosenmayr A, Höcker P, Kalhs P.
    Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
    [Abstract] [Full Text] [Related]

  • 16. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 17. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN, Yegin ZA, Yenicesu I, Aki SZ, Yagci M, Sucak GT.
    Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
    [Abstract] [Full Text] [Related]

  • 18. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
    Russell CA, Heilmann C, Madsen HO, Vindeløv LL.
    Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
    [Abstract] [Full Text] [Related]

  • 19. ABO incompatible stem cell transplantation in children does not influence outcome.
    Helming AM, Brand A, Wolterbeek R, van Tol MJ, Egeler RM, Ball LM.
    Pediatr Blood Cancer; 2007 Sep; 49(3):313-7. PubMed ID: 16960869
    [Abstract] [Full Text] [Related]

  • 20. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
    Mehta J, Powles R, Singhal S, Horton C, Hamblin M, Zomas A, Saso R, Treleaven J.
    Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.